Rapid and scalable full-length amplicon validation with Oxford Nanopore sequencing
)
Overview
In biopharmaceutical research and development, synthetic biology plays a central role in driving innovation, from engineering cell lines and gene therapy vectors to optimising antibody constructs and CRISPR-based editing tools. These complex and iterative workflows demand precise, rapid validation of sequence integrity to ensure therapeutic potential is not compromised.
Amplicon sequencing is essential at multiple points in this pipeline, and Oxford Nanopore technology provides a fast, simple, and scalable end-to-end workflow for amplicon sequencing.
In this workflow, you will:
- Find out how Oxford Nanopore technology delivers full-length amplicon sequencing, without the need for primers during the sequencing process
- Discover our best practice sequencing workflow in detail, starting from the recommended extraction method, through to primary analysis
- Learn about our recommended sequencing kit and devices
